Govt to soon decrease gap between 2nd dose of Covid vaccine and booster dose to 6 months Medical Dialogues Bureau29 April 2022 4:00 PM ISTA recommendation on lessening the gap is expected to be made by the National Technical Advisory Group on Immunisation (NTAGI) which is set to hold a...
Moderna seeks USFDA emergency use nod for COVID vaccine in children younger than 6 Ruchika Sharma29 April 2022 11:59 AM ISTModerna is also currently studying booster doses for all pediatric cohorts.
COVID-19 vaccination reduces infection, hospitalization and mortality in heart transplant recipients: JAMA Medical Dialogues Editorial Team29 April 2022 12:45 AM ISTUSA: Patients who have received an orthotopic heart transplant (OHT) and are infected with SARS-CoV-2 are at a higher risk of severe illness and...
Pfizer seeks USFDA emergency use nod for COVID booster in children aged 5 through 11 years Ruchika Sharma28 April 2022 3:22 PM ISTNew York: Pfizer Inc. and BioNTech SE have submitted an application to the U.S. Food and Drug Administration (USFDA) for Emergency Use Authorization...
Maternal administration of RSVpreF Vaccine Prevents RSV Infection in Infants: NEJM MD Bureau28 April 2022 9:30 AM ISTRespiratory syncytial virus (RSV), a major cause of illness and death in infants worldwide, could be prevented by vaccination during pregnancy. A...
Coronavirus vaccine: DCGI grants emergency use nod to Covaxin, Corbevax, ZycovD for different age group of children MD Bureau26 April 2022 5:00 PM ISTDCGI approved restricted use for emergency situation to ZycovD for children above the age of 12 years for a two-dose regimen.
GSK- CureVac experimental COVID variant vaccine effective in mice study Ruchika Sharma24 April 2022 9:15 AM ISTFrankfurt: CureVac and GSK's second-generation vaccine candidate targeting two recent COVID-19 variants has been shown to be highly...
DCGI panel asks Bharat Biotech to provide additional data on Covaxin for 2-12 years old Ruchika Sharma23 April 2022 2:49 PM ISTNo recommendations have been made as of now, sources told ANI.
Early trial of Novavax COVID-Influenza vaccine shows promise Ruchika Sharma23 April 2022 10:00 AM ISTThe safety and tolerability profile of the combination vaccine was consistent with the stand-alone NVX-CoV2373 and quadrivalent nanoparticle influenza...
Biological E gets CDSCO panel nod for Corbevax EUA for 5-11 years old Ruchika Sharma22 April 2022 1:10 PM ISTBiological E's Corbevax is being used to inoculate children against COVID-19 in the age group of 12 to 14 years.
Moderna to file for COVID vaccine EUA for children under 6 Ruchika Sharma22 April 2022 10:53 AM ISTNew Delhi: Moderna plans to submit an application to the US health regulator for emergency use authorization (EUA) of its Covid-19 vaccine among kids...
New Delhi: Free Precautionary dose of COVID 19 at all Govt CVCs MD Bureau21 April 2022 10:13 PM ISTNew Delhi: The precaution doses for all eligible beneficiaries will be available free of cost at all government vaccination centres in Delhi, it was...
